多参数方法预测三阴性乳腺癌:包括超快速动态增强MRI衍生参数
这项回顾性单中心研究纳入2015年12月至2020年5月间表现为肿块型乳腺癌的187例女性(191个病灶,其中33个为三阴性乳腺癌),评估超快速动态增强MRI的最大斜率(MS)和强化时间(TTE)、DWI的ADC值以及超快速和早期动态增强MRI上的边缘强化,构建预测三阴性乳腺癌的多参数模型,其AUC为0.74(95%CI 0.65, 0.84)。
要点
- 超快速动态增强MRI的最大斜率(MS)和早期动态增强MRI上的边缘强化是多变量分析后仍显著的预测三阴性乳腺癌的参数。
- 由上述显著参数构建的预测模型AUC为0.74(95%CI 0.65, 0.84)。
- 表达PD-L1的三阴性乳腺癌相比不表达PD-L1者似乎有更高的边缘强化率。
核心结论
- 使用超快速和早期动态增强MRI参数的多参数模型可能是识别三阴性乳腺癌的潜在影像生物标志物。
研究设计与样本
- 回顾性单中心研究,2015年12月至2020年5月间纳入187例女性(191个肿块型乳腺癌病灶,其中33个为三阴性乳腺癌),在超快速动态增强MRI后立即行早期动态增强MRI,采用组内相关系数(ICC)和Cohen kappa评估观察者间一致性,并行单变量和多变量logistic回归分析以预测三阴性乳腺癌并建立预测模型。
关键影像表现/征象
- 超快速动态增强MRI的最大斜率(MS)和早期动态增强MRI上的边缘强化在多变量分析后仍为显著参数。
- 表达PD-L1的三阴性乳腺癌相比不表达PD-L1的三阴性乳腺癌似乎有更高的边缘强化率。
诊断标准与关键数值
- 最大斜率(MS)、强化时间(TTE)、ADC值和病灶大小的ICC分别为0.95、0.97、0.83和0.99。
- 超快速和早期动态增强MRI上边缘强化的kappa值分别为0.88和0.84。
- 由MS和早期动态增强MRI边缘强化构建的预测模型AUC为0.74(95%CI 0.65, 0.84)。
临床应用与阅片要点
- 在表现为肿块的浸润性乳腺癌中,可结合超快速动态增强MRI的最大斜率(MS)和早期动态增强MRI的边缘强化辅助预测三阴性乳腺癌。
- 预测三阴性乳腺癌或非三阴性乳腺癌在诊断早期至关重要,有助于确定合适的临床管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Triple-negative breast cancer (TNBC) is a highly proliferative breast cancer subtype. We aimed to identify TNBC among invasive cancers presenting as masses using maximum slope (MS) and time to enhancement (TTE) measured on ultrafast (UF) DCE-MRI, ADC measured on DWI, and rim enhancement on UF DCE-MRI and early-phase DCE-MRI.
METHODS: This retrospective single-center study, between December 2015 and May 2020, included patients with breast cancer presenting as masses. Early-phase DCE-MRI was performed immediately after UF DCE-MRI. Interrater agreements were evaluated using the intraclass correlation coefficient (ICC) and Cohen's kappa. Univariate and multivariate logistic regression analyses of the MRI parameters, lesion size, and patient age were performed to predict TNBC and create a prediction model. The programmed death-ligand 1 (PD-L1) expression statuses of the patients with TNBCs were also evaluated.
RESULTS: In total, 187 women (mean age, 58 years ± 12.9 [standard deviation]) with 191 lesions (33 TNBCs) were evaluated. The ICC for MS, TTE, ADC, and lesion size were 0.95, 0.97, 0.83, and 0.99, respectively. The kappa values of rim enhancements on UF and early-phase DCE-MRI were 0.88 and 0.84, respectively. MS on UF DCE-MRI and rim enhancement on early-phase DCE-MRI remained significant parameters after multivariate analyses. The prediction model created using these significant parameters yielded an area under the curve of 0.74 (95% CI, 0.65, 0.84). The PD-L1-expressing TNBCs tended to have higher rim enhancement rates than the non-PD-L1-expressing TNBCs.
CONCLUSION: A multiparametric model using UF and early-phase DCE-MRI parameters may be a potential imaging biomarker to identify TNBCs.
CLINICAL RELEVANCE STATEMENT: Prediction of TNBC or non-TNBC at an early point of diagnosis is crucial for appropriate management. This study offers the potential of UF and early-phase DCE-MRI to offer a solution to this clinical issue.
KEY POINTS: • It is crucial to predict TNBC at an early clinical period. • Parameters on UF DCE-MRI and early-phase conventional DCE-MRI help in predicting TNBC. • Prediction of TNBC by MRI may be useful in determining appropriate clinical management.
引用
- Ohashi, Kataoka, Iima, et al. A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI. Eur Radiol. 2023. PMID: 37286791. doi:10.1007/s00330-023-09730-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。